1.
Namrata Bhutani, Huda Naaz, Amol Parshuram Anbhule, Inderpreet Kaur, Tejinder Singh and Jaswant Kaur. Targeted Therapy for CML Patients on Imatinib: Role of Novel Variants of Human Organic Cationic Transporter 1 (hOCT1). DHRNI-V3 [Internet]. 2024 Aug. 16 [cited 2026 Jun. 5];:81-7. Available from: https://stm.bookpi.org/DHRNI-V3/article/view/15443